• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,022
93
67
64
53

COUNTRY

61
13
11
8
6

CATEGORIES

  • 83
  • 122
  • 65
  • 63
  • 37
  • 33
  • 10
  • 10
  • 12
  • 16

PRICE

141
609
909
2,764

PUBLISHED

76
217
598
2,764

PRODUCT TYPE

2,651
94
9
6
2
2

Oncology

(2,764 Products)

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Glioblastoma Multiforme Treatment (GBM) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 Glioblastoma Multiforme Treatment (GBM) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 - Product Thumbnail Image

Glioblastoma Multiforme Treatment (GBM) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

Glioblastoma multiforme (GBM) is the most frequent and lethal primary brain tumor in adults. The current treatment modalities available in the market are surgical resection followed by chemotherapy...

June 2015
FROM
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

July 2015
FROM

Global Oncology/Cancer Drugs Market (Therapeutic Modalities, Cancer Types and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer...

February 2015
FROM
CINV Existing and Pipeline Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 CINV Existing and Pipeline Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 - Product Thumbnail Image

CINV Existing and Pipeline Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

'CINV Existing and Pipeline Drugs Market (Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL and Rolapitant) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020' Chemotherapy...

December 2014
FROM
Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends - Product Thumbnail Image

Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends

'Cervical Cancer Diagnostic Tests Market (Tests (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others (Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)) -...

November 2014
FROM

Global Oncology Ablation Market Outlook: 2014-2020

Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer...

November 2014
FROM

Corporate Reputation of Pharma in 2014 - a Perspective of Cancer Patient Groups - 2nd Edition

- Findings based on a survey of 197 patient groups with an interest in cancer from 37 countries - Survey conducted November 2014 to January 2015 This independent study, funded by the author, represents...

March 2015
FROM

Global Kidney Cancer Drugs Market 2015-2019

About Kidney Cancer Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease...

July 2015
FROM

Global Colorectal Cancer Drugs Market 2015-2019

About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature...

June 2015
FROM

Global Cancer Vaccines Market 2015-2019

About Cancer Vaccines Cancer vaccines are biological preparations that stimulate or strengthen a person’s immune system against cancer. Cancer vaccines are usually administered intravenously. They...

June 2015
FROM

Global Prostate Cancer Devices Market 2015-2019

About Prostate Cancer Prostate cancer is one of the most common cancer in men. It occurs in the prostate gland, a small walnut-shaped gland. The primary function of the prostate gland is to produce...

June 2015
FROM

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and...

March 2015
FROM

HER-2 Positive Breast Cancer Market in the US 2015-2019

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer...

March 2015
FROM

Global HER-2 Positive Breast Cancer Market 2015-2019

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer...

March 2015
FROM

Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025

Over decades, the oncology market has been led by surgery, chemotherapy and radiotherapy. The non-specificity of chemotherapy/radiotherapy and limitations of surgery has expanded the focus of many pharmaceutical...

April 2015
FROM

Global Lung Cancer Therapeutics Market 2015-2019

About Lung Cancer Cancer occurs when, after undergoing cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in both developed...

November 2014
FROM

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM

Immune Checkpoint Inhibitors Market, 2014 - 2024

Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to...

November 2014
FROM

Global Prostate Cancer Drugs Market 2014-2018

About Prostate Cancer Prostate cancer initiates in the prostate, which is an exocrine gland present in the male reproductive system. The main function of the prostate is to make fluid for semen. The...

November 2014
FROM

Global Oncology Biosimilars Market 2014-2018

About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have...

November 2014
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)